Check out your Company Bowl for anonymous work chats.
BBFH Series IDE’s BBFH Series, hosted by IDE Group, is a series of interviews with former winners, judges and contestants of the annual Building Better Futures for Health (BBFH) Challenge Episode 1: Our host, Richard Sokolov, Executive Director and co-founder of IDE Group. Interview with Michael Brooks – Head of Bayer Radiology and long-time judge of IDE’s BBFH Challenge.
Do you have an idea for healthcare products and services that can improve and change people’s lives? Apply now for the BBFH Challenge 2021! 🚀 Entrepreneurs, researchers and industry professionals worldwide are invited to apply for the Building Better Futures for Health Challenge. The winners receive up to $30,000 worth of design and entrepreneurial support from IDE Group, bringing your idea to life and kick-starting our journey together to commercialisation. BBFH provides finalists and winners with the unique opportunity to obtain advice, mentorship, and financial guidance from IDE and the select judging panel. Collectively you will have access to a cross-functional team of entrepreneurs, scientists, designers, engineers, and clinical professionals. Bringing an established network of knowledge, experiences, and connections in the medical technology field. George Sidis, Managing Director of IDE Group, explains the philosophy of BBFH, “The BBFH challenge is about working together to find, create, evaluate and invest in Australia’s best medical technology innovations. "
We are very excited to running our Building Better Futures Challenge 2021. Applications will be opening very soon. Join our newsletter to stay up to date. #BBFH21 Do you have an idea? That can make a difference to People’s Health. Entrepreneurs, researchers and industry professionals worldwide are invited to apply for the Building Better Futures for Health Challenge. The winners could receive up to $30,000 worth of design and entrepreneurial support from IDE Group, bringing your idea to life and kick-starting our journey together to commercialisation.